Resonant Therapeutics
Founded
2016
2016
Geography
United States of America based
United States of America based
Funding
$1.960 M
$1.960 M
Website
http://resonantrx.com/
http://resonantrx.com/
Developer of novel therapeutics designed to treat cancer. The Company's proprietary platform focuses on the tumor microenvironment and data science to identify novel tumor-selective targets and anti-tumor antibodies with unprecedented speed.
Technologies
AI Companies (Drug Discovery)R&D Platform
Assess and prioritize a library of drug candidates derived from analyzing tumor microenvironments. Allows researchers to: Simultaneously discover novel targets and functional antibodies for cancer.
Pipelines
No pipelines published yet
Products
Services
No services posted yet
